Evidence map›Paper›PMID 22128066›Full record

ArticleGenetic epidemiology2011

Regression and data mining methods for analyses of multiple rare variants in the Genetic Analysis Workshop 17 mini-exome data.

Joan E Bailey-Wilson, Jennifer S Brennan, Shelley B Bull, Robert Culverhouse, Yoonhee Kim, Yuan Jiang, Jeesun Jung, Qing Li, Claudia Lamina, Ying Liu and 7 more

Abstract read
In one paragraph

Article in Genetic epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Joan E Bailey-WilsonInherited Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Baltimore, MD 21224, USA. jebw@mail.nih.gov
Jennifer S Brennan
Shelley B Bull
Robert Culverhouse
Yoonhee Kim
Yuan Jiang
Jeesun Jung
Qing Li
Claudia Lamina
Ying Liu
Reedik Mägi
Yue S Niu
Claire L Simpson
Libo Wang
Yildiz E Yilmaz
Heping Zhang
Zhaogong Zhang

Funding

GENETIC ANALYSIS OF COMMON DISEASES: AN EVALUATIONR01GM031575 · NIGMS · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 1985 to 2016
$7.8M
Development of statistical genetics methodologyZIAHG000153 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BAILEY-WILSON, JOAN ELLEN · 2009 to 2022
$5.0M
RESEARCH TRAINING IN MENTAL HEALTH EPIDEMIOLOGYT32MH014235 · NIMH · YALE UNIVERSITY · PI ZHANG, HEPING · 1985 to 2014
$4.0M
DEVELOPING STRATEGIES FOR JOINT GENE-ENVIRONMENT ANALYSISR21DA033827 · NIDA · WASHINGTON UNIVERSITY · PI CULVERHOUSE, ROBERT C · 2011 to 2012
$418k
CIHR 84287-1Intramural NIH HHS ZIA HG000153NIDA NIH HHS R21 DA033827NIGMS NIH HHS R01 GM031575NIMH NIH HHS T32 MH014235NIMH NIH HHS T32 MH-14235
6 · The paper itself

Abstract

Group 14 of Genetic Analysis Workshop 17 examined several issues related to analysis of complex traits using DNA sequence data. These issues included novel methods for analyzing rare genetic variants in an aggregated manner (often termed collapsing rare variants), evaluation of various study designs to increase power to detect effects of rare variants, and the use of machine learning approaches to model highly complex heterogeneous traits. Various published and novel methods for analyzing traits with extreme locus and allelic heterogeneity were applied to the simulated quantitative and disease phenotypes. Overall, we conclude that power is (as expected) dependent on locus-specific heritability or contribution to disease risk, large samples will be required to detect rare causal variants with small effect sizes, extreme phenotype sampling designs may increase power for smaller laboratory costs, methods that allow joint analysis of multiple variants per gene or pathway are more powerful in general than analyses of individual rare variants, population-specific analyses can be optimal when different subpopulations harbor private causal mutations, and machine learning methods may be useful for selecting subsets of predictors for follow-up in the presence of extreme locus heterogeneity and large numbers of potential predictors.

Indexed as

Regression AnalysisArtificial IntelligenceData Interpretation, StatisticalData MiningExomeGenetic Predisposition to DiseaseGenetic VariationHuman Genome ProjectHumansMeta-Analysis as TopicMolecular EpidemiologyPolymorphism, Single NucleotideSequence Analysis

Identifiers

PMID22128066
PMCPMC3360949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.